| 2019 | | 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea | 김대중 |
| 2019 | | A Path Analysis of Effects of Patients' Underlying Conditions, Treatment Satisfaction, and Adherence on Quality of Life Among Korea Glaucoma Patients | 안재홍 |
| 2010 | | An anaphylactic reaction caused by levodropropizine. | 박해심 |
| 2022 | | Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort | 박래웅, 임홍석 |
| 2016 | | Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III Study | 윤명호 |
| 1998 | | Cardioprotective effects of KR-30450, a novel K+(ATP) opener, and its major metabolite KR-30818 on isolated rat hearts. | 문창현, 정이숙 |
| 2018 | | Central and cerebral haemodynamic changes after antihypertensive therapy in ischaemic stroke patients: A double-blind randomised trial | 박래웅, 윤덕용, 이성준, 이진수, 최문희, 홍지만 |
| 1999 | | Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist. | 이수환, 정이숙 |
| 2016 | | Characterizing treatment pathways at scale using the OHDSI network | 박래웅 |
| 2021 | | Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up | 임홍석 |
| 2023 | | Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis | 최창영 |
| 2024 | | Comparative estimation of the effects of antihypertensive medications on schizophrenia occurrence: a multinational observational cohort study | 박래웅, 손상준 |
| 2018 | | Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study | 황교승 |
| 2006 | | Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial. | 윤명호 |
| 2017 | | Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study | 신준한 |
| 2012 | | Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study | 윤명호 |
| 2016 | | Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter Study | 탁승제 |
| 2021 | | Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study | 박래웅 |
| 2011 | | Detection of masked hypertension and the 'mask effect' in patients with well-controlled office blood pressure. | 신준한 |
| 2006 | | Diazoxide acts more as a PKC-epsilon activator, and indirectly activates the mitochondrial K(ATP) channel conferring cardioprotection against hypoxic injury. | 문창현, 백은주, 이수환, 정이숙 |
| 2022 | | Does severe subacute noise exposure increase risk of new onset hypertension beyond conventional risk factors? A 30 000 person-years cohort study | 정인철 |
| 2017 | | Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study | 김대중, 김혜진, 이관우, 한승진 |
| 2020 | | Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia | 최소연 |
| 2016 | | Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong) | 박진선, 신준한 |
| 2022 | | Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial | 신준한 |
| 2016 | | Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial | 신준한 |
| 2012 | | Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies | 신준한 |
| 2019 | | Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study | 윤명호 |
| 2015 | | Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy. | 신준한 |
| 2015 | | Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial. | 신준한 |
| 2016 | | Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension | 강대용 |
| 2019 | | mAHTPred: a sequence-based meta-predictor for improving the prediction of anti-hypertensive peptides using effective feature representation | Balachandran, Manavalan, Basith, Shaherin, 신태환, 이광 |
| 2021 | | Pearls & Oy-sters: Cerebral Microbleeds Caused by Adrenocortical Adenoma-Related Primary Aldosteronism | 김장희, 김형규, 문소영, 박진선, 이기황, 이선민, 임용철, 최용준 |
| 1998 | | Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus. | 문창현, 백은주, 이수환, 이희주, 정이숙 |
| 1999 | | Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog. | 이수환, 정이숙 |
| 2024 | | Phase III randomized clinical trial of efficacy and safety of amlodipine and candesartan cilexetil combination for hypertension treatment | 소문승, 임홍석 |
| 2018 | | S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial | 신준한 |
| 2016 | | Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS Study | 신준한 |
| 2017 | | Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry | 김현아, 서창희 |
| 2017 | | Treatment patterns and medication adherence of patients with glaucoma in South Korea | 안재홍 |
| 2021 | | Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data | 김유찬, 최지웅 |
